Skip to main content
. 2018 Dec 11;9:758. doi: 10.3389/fendo.2018.00758

Figure 3.

Figure 3

Proposed role of doxorubicin in an obesogenic breast cancer model. ACC, Acetyl-CoA carboxylase; CD36, fatty acid translocase; FFA, free fatty acids; FABP, fatty acid binding protein; FABP-4, fatty acid binding protein-4; FAS, fatty acid synthase; HSL, hormone sensitive lipase; PPAR-γ, peroxisome proliferator-activated receptor-γ; TAGs, triglycerides.